International Day of People with Disabilities 2022

The theme this year is “Transformative solutions for inclusive development: the role of innovation in fuelling an accessible and equitable world“.

The annual observance of the International Day of Persons with Disabilities (IDPD) on 3 December was proclaimed in 1992 by the United Nations General Assembly resolution 47/3. The observance of the Day aims to promote an understanding of disability issues and mobilize support for the dignity, rights and well-being of persons with disabilities.

The 2022 global observance to commemorate the International Day of Persons with Disabilities will be around the overarching theme of innovation and transformative solutions for inclusive development, covering in three different interactive dialogues the following thematic topics:

Innovation for disability inclusive development in employment (SDG8): this dialogue will discuss the linkages between employment, knowledge and skills required to access employment in an innovative, rapidly changing technological landscape to all and how assistive technologies can increase accessibility to employment and be mainstreamed in the workplace.

Innovation for disability inclusive development in reducing inequality (SDG10): this dialogue will discuss innovations, practical tools and good practices to reduce inequalities in both public and private sectors, which are disability inclusive and interested in promoting diversity in the workplace.

Innovation for disability inclusive development: sport as an exemplar case: a sector where all of these aspects coalesce; sport as a good practice example and a site of innovation, employment and equity.

Table of contents

Elsevier, The Lancet Regional Health - Europe, Volume 22, November 2022
This Article supports SDGs 3 and 10, examining the mortality risk for people aged 25-44 years with disability, and shows that the risk increases with different types and severities of disability and is particiularly associated with mental health problems and motor impairment
Elsevier, Preventive Medicine Reports, Volume 29, October 2022
People with any disabilities accounted for a quarter of total deaths. People with disabilities had higher average ages and poor economic conditions. All disability types presented higher mortality rates and lower life expectancy. The major causes of death differed according to the type of disability.
Elsevier, Clinical Imaging, Volume 90, October 2022
Several studies of adult-onset multiple sclerosis (AOMS) patients have demonstrated that spinal cord volume loss is associated with disease progression and clinical disability; however, complementary studies of young patients with pediatric-onset multiple sclerosis (POMS) are lacking. In the context of SDG Goal 3, this retrospective study aimed to assess spinal cord volume in POMS patients compared with that in healthy controls.
Elsevier, The Lancet Psychiatry, Volume 9, September 2022
This Article supports SDGs 3 and 10, assessing the effects of genomics, inheritance, and socioeconomic deprivation on neuropsychiatric risk in children with intellectual disabilities. The study shows that children with genomic variants and intellectual disability are at increased risk of neuropsychiatric difficulties.
Elsevier,

Journal of Mathematical Behavior, Volume 67, September 2022

How adapting math instruction for those with learning disabilities can allow them to increase their understanding of mathematics. Supports SDGs 4 and 10.
Elsevier, Engineering Applications of Artificial Intelligence, Volume 114, September 2022
Development of a siren identification system, using deep learning, for hearing-impaired people. Supports SDG 10.
Elsevier, The Lancet Regional Health - Europe, Volume 18, July 2022
This Article supports SDGs 3 and 10, assessing the effect of housing modifications of disability outcomes, with a particular focus on the ageing population.
Elsevier, The Lancet Rheumatology, Volume 4, July 2022
An Article in support of SDG 3, examining the treatment pathway for hip replacements over the life of the patient in terms of risk of revision and re-revisions.
Elsevier, American Journal of Medicine, Volume 135, July 2022
In a 2019 national survey, 3.1% (95% confidence interval, 2.6%-3.5%) of practicing US physicians self-reported a disability, as defined by the Americans with Disabilities Act.2 Although the prevalence of reported disabilities in physicians is less than the general population, physicians may choose to not disclose their disabilities, especially hidden disabilities.
Elsevier,

Journal of Aging Studies, Volume 61, June 2022

An investigation of the support needed for the visually impaired to be able to age successfully.
Elsevier, Clinical Breast Cancer, Volume 22, April 2022
The aim of this study was to evaluate the effects of complete decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL), in regard to volume reduction, functional status and quality of life (QoL). In th context of SDG Goal 3, the study found that phase 1 CDT in a combined manner performed daily for 3 weeks, greatly reduces the volumes as well as improves the disability and QoL, especially when performed earlier.
Elsevier,

The Lancet Global Health, Volume 10, March 2022

This Viewpoint supports SDGs 3 and 10 by arguing that greater attention and emphasis should be placed on children with developmental disabilities in early childhood development strategies, which would necessitate funding and investment specifically for this patient population.
Elsevier, Preventive Medicine, Volume 156, March 2022
Average age at death is younger for intellectual and developmental disabled adults. This disparity is more pronounced among all racial-ethnic minorities. Racial-ethnic inequities are most severe among adults with cerebral palsy.
Elsevier, The Lancet Public Health, Volume 7, January 2022
The COVID-19 pandemic is unprecedented. The pandemic not only induced a public health crisis, but has led to severe economic, social, and educational crises. Across economies and societies, the distributional consequences of the pandemic have been uneven. Among groups living in vulnerable conditions, the pandemic substantially magnified the inequality gaps, with possible negative implications for these individuals' long-term physical, socioeconomic, and mental wellbeing.
Elsevier, The Lancet Global Health, Volume 10, January 2022
Background: To address the growing prevalence of hearing loss, WHO has identified a compendium of key evidence-based ear and hearing care interventions to be included within countries’ universal health coverage packages. To assess the cost-effectiveness of these interventions and their budgetary effect for countries, we aimed to analyse the investment required to scale up services from baseline to recommended levels, and the return to society for every US$1 invested in the compendium.
Elsevier, The Lancet Planetary Health, Volume 5, December 2021
This Personal View supports SDGs 3 and 13, drawing attention to how the lived experiences of disability can deepen understanding of climate-resilient development, and how marginalisation increases vulnerability. The paper stresses the importance of solidarity in underpinning social choices.
Elsevier, The Lancet Global Health, Volume 9, December 2021
An Article in support of SDG 3, estimating the global burden of tuberculosis, inclusive of post-tuberculosis morbidity and mortality, in view of the increasing evidence of long-term disability and elevated mortality risks in tuberculosis survivors.
Diagram showing the age-adjusted cumulative COVID-19 mortality between Jan 24, 2020, and Feb 28, 2021, by disability status and sex. Upper and lower lines of each colour represent the upper and lower bounds of the bootstrapped 95% CI.
Elsevier, The Lancet Public Health, Volume 6, November 2021
Background: People with learning disabilities are at substantially increased risk of COVID-19 mortality, but evidence on risks of COVID-19 mortality for disabled people more generally is limited. We aimed to use population-level data to estimate the association between self-reported disability and death involving COVID-19 during the first two waves of the COVID-19 pandemic in England.
Elsevier, EClinicalMedicine, Volume 39, September 2021
This Research Paper supports SDGs 3 and 10 by investigating the contribution of multiple long-term conditions to the widening inequalities in disability-free life expectancy by socioeconomic deprivation.
Elsevier, The Lancet Public Health, Volume 6, June 2021
Background: The COVID-19 pandemic has affected mental health, psychological wellbeing, and social interactions. People with physical disabilities might be particularly likely to be negatively affected, but evidence is scarce. Our aim was to evaluate the emotional and social experience of older people with physical disabilities during the early months of the COVID-19 pandemic in England.
Elsevier, The Lancet Global Health, Volume 9, February 2021
An Article in support of SDG 3, showing that the age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs and vision impairment remains an urgent and increasingly important public health priority.
Elsevier,

The Neuroscience of Autism, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing different levels and magnitude of explanation for the various behavioral symptoms seen in individuals with ASD, collectively providing a comprehensive picture of this disorder.
Elsevier,

The Neuroscience of Autism, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the history and evolution of the definition and characterization of autism over the past several decades and the impact of it on how the disorder is perceived by autistic individuals, families, and professionals
Elsevier,

The Chromosome 22q11.2 Deletion Syndrome
A Multidisciplinary Approach to Diagnosis and Treatment
2022, Pages 322-337

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing a biopsychosocial approach that is key to optimal outcomes for patients with psychiatric illnesses.
Elsevier,

Foundations of Art Therapy: Theory and Applications, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining race, ethnicity, culture, national origin, color, gender, gender identity, sexual orientation, class, age, marital status, political belief, religion, geographic region, mental or physical disability, and historical or current experiences with the dominant culture to fully understand human behavior.
Elsevier,

Mental Health in a Digital World, Volume , 1 January 2021

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring the quality of online information on neurodevelopmental disorders, eating disorders, psychotic disorders, and mood and anxiety disorders.
Elsevier,

Biomedical Engineering Applications for People with Disabilities and the Elderly in the COVID-19 Pandemic and Beyond, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the impact of the COVID-19 pandemic on the physical and mental health of the elderly.
Elsevier,

Aging
From Fundamental Biology to Societal Impact
2023, Pages 725-744

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting early evidence on what it meant to be a frail older individual in the COVID-19 pandemic from the perspective of three different settings: community, hospitals, and nursing homes. Lessons learned provide opportunities to improve health outcomes, community and health services, and how we want to live as aging societies.
Elsevier,

Integrating Mental Health and Disability Into Public Health Disaster Preparedness and Response
2022, Pages 73-94

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by focusing on the impacts of emergencies, disasters, and the COVID-19 pandemic on people with disabilities and chronic and mental health conditions
Elsevier,

Integrating Mental Health and Disability Into Public Health Disaster Preparedness and Response
2022, Pages 55-72

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by looking at policies and frameworks for disaster risk reduction to ensure disability-inclusive disaster risk reduction practices across the world
Elsevier,

The COVID-19 Response
The Vital Role of the Public Health Professional
2023, Pages 69-84

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring the impact of COVID-19 on employment, childcare, food security, and mental health.
Elsevier,

The COVID-19 Response
The Vital Role of the Public Health Professional
2023, Pages 101-118

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining the consequences of failing to adequately address long-standing social determinants and structural disparities related to the public's health
Elsevier,

Adolescent Mental Health
Towards Technological Advances and Service Innovations
2023, Pages 111-144

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting available evidence of the effects of acute COVID-19 illness on children and young people, the impact on at-risk groups, and access to mental health services and education during the pandemic, as well as discussing the implications and recommendations for research, practice, and policy.
Elsevier,

Developments in Neuroethics and Bioethics
Volume 5, 2022, Pages 39-67

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by outlining key aspects of disability studies and considers how this strongly emerging field is intersecting with scholarship and activism across many varieties of neurodivergence
Elsevier,

Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics, Volume , 1 January 2021

This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced inequalities by showing the effectiveness of neural mobilization on pain and disability in individuals with musculoskeletal disorders.
Elsevier,

Modern Practical Healthcare Issues in Biomedical Instrumentation 2022, Pages 105-121

This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by focusing on the physically impaired who are unable to move about or carry out their day-to-day tasks independently in light of a new system with features that ensures a smooth and easy transition to a substantially improved quality of life.
Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring novel and advanced personalized medicine approaches to tailor depression treatments.
Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the evidence base for treatment of youth with depression, with a focus on management of treatment-resistant depression.
Elsevier,

Herbal Medicines: A Boon for Healthy Human Life, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring herbal medicines role in depression to provide alternatives to current psychiatric drugs which may cause many induced side effects.
Elsevier,

Epigenetics of Stress and Stress Disorders, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by examining Pharmacoepigenetics as an emerging field and the relation of epigenetic mechanisms to treatment response to inform treatment selection.
Elsevier,

Artificial Intelligence, Machine Learning, and Mental Health in Pandemics: A Computational Approach, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting the design, execution, and test results of the dyslexia health management system; and highlighting the high potential for worldwide deployment using blockchain technology.
Elsevier,

Pickwell's Binocular Vision Anomalies (Sixth Edition)
2022, Pages 91-95

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing diagnostic occlusion and investigative occlusion for better patient outcomes..
Elsevier,

Biosignal Processing and Classification Using Computational Learning and Intelligence: Principles, Algorithms, and Applications, Volume , 1 January 2021

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by presenting EEG and machine learning approaches to the classification of attention deficit and hyperactivity disorders for the improvement of specificity, reducing over diagnosis and under diagnoses, thereby avoiding undesirable consequences in adulthood.
Elsevier,

Psychiatric Clinics of North America, Volume 45, June 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by discussing how the inclusion of mental health providers with disabilities can improve the quality of patient care, and can add value to medical student and resident education.
Elsevier,

Managing Treatment-Resistant Depression: Road to Novel Therapeutics, Volume , 1 January 2022

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by reviewing the data on clinical and epidemiological predictors of antidepressant response, or predictors of treatment-resistant depression and discussing the possible prognostic value of clinical features, like severity, chronicity, subtypes of depression, comorbidities, history of trauma, and epidemiological features like gender, age, sociodemographic status.